Why Jensen Huang’s Company Is Betting On Recursion Pharmaceuticals, Inc. (RXRX)
We recently compiled a list of the 5 Stocks Jensen Huang’s Company is Betting On. In this article, we are going to take a ...
Why Recursion Pharmaceuticals Stock Is Soaring Today
Many investors seemed to view Nvidia's decision to maintain its stake in Recursion as a vote of confidence in the company.
Recursion: CDK7 Inhibitor Differentiation Is Initially Paying Off
Recursion is advancing REC-617, a promising reversible, non-covalent CDK7 inhibitor, showing potential in treating advanced solid tumors with positive interim phase 1 data. Read more here.